1-800-TEMPLE-MED

News & Announcements
Page size:
select
 2815 items in 282 pages
 
Page size:
select
 2815 items in 282 pages

Temple University Hospital Earns ANCC Magnet Recognition

Temple University Hospital has achieved Magnet designation from the American Nurses Credentialing Center (ANCC), considered the highest honor and form of recognition for nursing excellence. read more »

Temple University Hospital Earns ANCC Magnet Recognition


(Philadelphia, PA) – Temple University Hospital has achieved Magnet designation from the American Nurses Credentialing Center (ANCC), considered the highest honor and form of recognition for nursing excellence. Only about 8 percent of U.S. health care organizations have achieved the honor of Magnet status.
read more »

Temple Researchers Identify Long-Sought Activator of Sigma Receptors in Human Cells, Marking Important Advance in Cell Biology

Researchers at the Lewis Katz School of Medicine at Temple University (LKSOM), in collaboration with scientists at the University of Cambridge, show that choline, an essential nutrient that functions in metabolism, is an endogenous activator of sigma-1 receptors, marking an important advance in cell biology. read more »

Temple Researchers Identify Long-Sought Activator of Sigma Receptors in Human Cells, Marking Important Advance in Cell Biology


(Philadelphia, PA) – Cells communicate through complex mechanisms that typically involve receptors and ligands that bind to them. Endogenous ligands, produced by the body, have been identified for the vast majority of cellular receptors, helping explain receptor existence and function. But in the case of sigma-1 receptors, which interact with a diverse array of psychoactive drugs, an endogenous ligand has remained elusive. Now, researchers at the Lewis Katz School of Medicine at Temple University, in collaboration with scientists at the University of Cambridge, show that choline, an essential nutrient that functions in metabolism, is an endogenous activator of sigma-1 receptors, marking an important advance in cell biology.
read more »

LKSOM Receives Donation from
Alzheimer’s Nonprofit to Conduct Study


(January 10, 2019) - Scientists at the Lewis Katz School of Medicine at Temple University (LKSOM) have received a $100,000 donation from the nonprofit organization Stop Alzheimer’s Now to study whether the inhibition of a specific protein in the brain can stimulate neurogenesis. Domenico Praticó, MD, the Scott Richards North Star Charitable Foundation Chair for Alzheimer’s Research; Professor and Director of the Alzheimer’s Center at Temple; and Professor of Pharmacology, Microbiology and Immunology at LKSOM, will lead the efforts.
read more »

Thomas Jefferson University and Temple University Enter Exclusive Negotiations

Jefferson to pursue purchase of Fox Chase Cancer Center read more »

Thomas Jefferson University and Temple University
Enter Exclusive Negotiations


(Philadelphia, PA) - Two of Philadelphia’s leading academic and healthcare organizations have signed an agreement that creates an exclusive 90-day window within which to consider and negotiate the acquisition and conduct due diligence by Jefferson of the Fox Chase Cancer Center.
> read more »

Lewis Katz School of Medicine at Temple University Receives $100,000 Donation from Stop Alzheimer’s Now to Conduct Groundbreaking Study


(Philadelphia, PA) – Beneath the amyloid plaques and neurofibrillary tangles that are the hallmark pathological features of Alzheimer's disease, is another, lesser-known anomaly: the almost complete absence of adult neurogenesis, the process by which new neurons form in the developed brain. Thought to serve a critical role in maintaining memory and learning ability, little is actually known about the significance of reduced adult neurogenesis in Alzheimer's disease. Now, scientists at the Lewis Katz School of Medicine at Temple University have a chance to find out, thanks to a $100,000 gift from Stop Alzheimer's Now, a non-profit organization dedicated to eradicating Alzheimer's disease.
read more »

Lewis Katz School of Medicine at Temple University Receives $100,000 Donation from Stop Alzheimer’s Now to Conduct Groundbreaking Study

The new study will test whether inhibition of a specific protein in the brain can stimulate neurogenesis. read more »

Dr. Justin Faden Discusses Treatment-Resistant Schizophrenia


(January 8, 2019) - Justin B. Faden, DO, Assistant Professor of Psychiatry & Behavioral Science at the Lewis Katz School of Medicine at Temple University, contributed comments to Psychiatry Advisor for an article about schizophrenia.
read more »